DE69929530D1 - Attenuierte pferdeherpesvirus - Google Patents
Attenuierte pferdeherpesvirusInfo
- Publication number
- DE69929530D1 DE69929530D1 DE69929530T DE69929530T DE69929530D1 DE 69929530 D1 DE69929530 D1 DE 69929530D1 DE 69929530 T DE69929530 T DE 69929530T DE 69929530 T DE69929530 T DE 69929530T DE 69929530 D1 DE69929530 D1 DE 69929530D1
- Authority
- DE
- Germany
- Prior art keywords
- ehv
- mutants
- relates
- attenuated
- vectors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16411—Rhadinovirus, e.g. human herpesvirus 8
- C12N2710/16461—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98202594 | 1998-07-31 | ||
EP98202594 | 1998-07-31 | ||
PCT/EP1999/005476 WO2000008165A1 (en) | 1998-07-31 | 1999-07-26 | Attenuated equine herpesvirus |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69929530D1 true DE69929530D1 (de) | 2006-04-06 |
DE69929530T2 DE69929530T2 (de) | 2006-07-20 |
Family
ID=8234001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69929530T Expired - Lifetime DE69929530T2 (de) | 1998-07-31 | 1999-07-26 | Attenuierter pferdeherpesvirus |
Country Status (9)
Country | Link |
---|---|
US (1) | US7060282B1 (de) |
EP (1) | EP1100925B1 (de) |
AT (1) | ATE316139T1 (de) |
AU (1) | AU758604B2 (de) |
BR (1) | BR9912626B1 (de) |
CA (1) | CA2337965C (de) |
DE (1) | DE69929530T2 (de) |
HU (1) | HUP0102861A3 (de) |
WO (1) | WO2000008165A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1129722A1 (de) | 2000-02-17 | 2001-09-05 | Boehringer Ingelheim Vetmedica Gmbh | GM-negative EHV Mutanten |
US7906311B2 (en) | 2002-03-20 | 2011-03-15 | Merial Limited | Cotton rat lung cells for virus culture |
AR040601A1 (es) | 2002-07-19 | 2005-04-13 | Boehringer Ingelheim Vetmed | Mutantes ehv negativos de gm sin elementos heterologos |
WO2005063991A2 (en) | 2003-12-19 | 2005-07-14 | Seattle Biomedical Research Institute | Live genetically attenuated malaria vaccine |
US7722860B2 (en) | 2004-12-03 | 2010-05-25 | Seattle Biomedical Research Institute | Live genetically engineered protozoan vaccine |
EP2247307A1 (de) * | 2007-12-21 | 2010-11-10 | GlaxoSmithKline Biologicals S.A. | Impfstoff |
AU2009277107B2 (en) * | 2008-07-30 | 2014-02-27 | University Of Kentucky Research Foundation | Equine disease model for herpesvirus neurologic disease and uses thereof |
HUE033739T2 (en) * | 2010-10-18 | 2018-01-29 | Intervet Int Bv | Turkey herpesvirus vector vaccine against avian influenza in poultry |
CA3036293A1 (en) | 2016-09-20 | 2018-03-29 | Boehringer Ingelheim Vetmedica Gmbh | New promoters |
UY37406A (es) | 2016-09-20 | 2018-03-23 | Boehringer Ingelheim Vetmedica Gmbh | Nuevo sitio de inserción orf70 de ehv |
CN109715219B (zh) | 2016-09-20 | 2024-03-01 | 勃林格殷格翰动物保健有限公司 | 犬腺病毒载体 |
EP3515480A1 (de) * | 2016-09-20 | 2019-07-31 | Boehringer Ingelheim Vetmedica GmbH | Neuer schweinegrippenimpfstoff |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9014951D0 (en) | 1990-07-06 | 1990-08-29 | Univ Glasgow | Equine herpesvirus-4 tk vaccine |
GB9415319D0 (en) | 1994-07-29 | 1994-09-21 | Medical Res Council | HSV viral vector |
-
1999
- 1999-07-26 BR BRPI9912626-5A patent/BR9912626B1/pt not_active IP Right Cessation
- 1999-07-26 AT AT99944307T patent/ATE316139T1/de not_active IP Right Cessation
- 1999-07-26 WO PCT/EP1999/005476 patent/WO2000008165A1/en active IP Right Grant
- 1999-07-26 EP EP99944307A patent/EP1100925B1/de not_active Expired - Lifetime
- 1999-07-26 AU AU57293/99A patent/AU758604B2/en not_active Ceased
- 1999-07-26 US US09/744,799 patent/US7060282B1/en not_active Expired - Fee Related
- 1999-07-26 CA CA002337965A patent/CA2337965C/en not_active Expired - Fee Related
- 1999-07-26 DE DE69929530T patent/DE69929530T2/de not_active Expired - Lifetime
- 1999-07-26 HU HU0102861A patent/HUP0102861A3/hu unknown
Also Published As
Publication number | Publication date |
---|---|
DE69929530T2 (de) | 2006-07-20 |
EP1100925A1 (de) | 2001-05-23 |
BR9912626B1 (pt) | 2010-09-08 |
CA2337965C (en) | 2009-12-15 |
WO2000008165A1 (en) | 2000-02-17 |
AU5729399A (en) | 2000-02-28 |
ATE316139T1 (de) | 2006-02-15 |
BR9912626A (pt) | 2001-04-24 |
AU758604B2 (en) | 2003-03-27 |
EP1100925B1 (de) | 2006-01-18 |
HUP0102861A3 (en) | 2005-03-29 |
US7060282B1 (en) | 2006-06-13 |
HUP0102861A2 (hu) | 2001-11-28 |
CA2337965A1 (en) | 2000-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69535359D1 (de) | Rekombinantes herpesvirus aus trufhähnen und seine verwendungen | |
DE69929530D1 (de) | Attenuierte pferdeherpesvirus | |
DK0707071T3 (da) | Rekombinante vektorer afledt fra adenovirus til anvendelse i genterapi | |
BR9205771A (pt) | Vetor de vírus recombinantes e processo para a fabricaçao do mesmo | |
KR900700508A (ko) | 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질 | |
YU6304A (sh) | Atenuirani virus besnila sa nukleoproteinskom mutacijom u mestu za fosforilaciju za vakcinaciju protiv besnila i gensku terapiju u cns-u | |
ATE346931T1 (de) | Clostridium perfringens impfstoff | |
DK0507179T3 (da) | Equine herpesvira (EHV), der indeholder fremmed | |
WO1994013812A3 (en) | Novel entomopoxvirus genes, proteins and methods of use thereof | |
AU4334193A (en) | Infectious bovine rhinotracheitis virus mutants and vaccines | |
BR9909173A (pt) | ácido nucleico, mutante de deleção de um alfa-vìrus, adenovìrus recombinante, vìrus vacìnia recombinante, plasmìdeo, vacina, e, processo para produzir uma imune resposta protetora a um alfa-vìrus | |
Elahi et al. | Recombinant adenoviruses expressing the E2 protein of bovine viral diarrhea virus induce humoral and cellular immune responses | |
AP2000001892A0 (en) | Self-replicating vector for DNA immunization against HIV. | |
DE69333074D1 (de) | Rekombitante, equine herpesviren | |
NO20005482D0 (no) | Rekombinant virus som uttrykker fremmed DNA som koder for Felin CD80, Felin CTLA-4 eller Felin CD86 og anvendelse derav | |
HUP9904201A1 (hu) | Génterápiában használható, egy exogén nukleinsavat genomjában beépítve tartalmazó rekombináns vírus és egy nem virális és nem plazmid transzfektáló szer kombinációját tartalmazó transzfektáló készítmény | |
WO1992014818A3 (en) | Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences | |
WO2004039400A3 (en) | Bhv5 mutants | |
Yamada et al. | Deletion of gene OV132 attenuates Orf virus more effectively than gene OV112 | |
ES2074965A1 (es) | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: INTERVET INTERNATIONAL B. V., AN BOXMEER, NL |